Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

FountainVest Raises $2.1 Billion for Third China PE Fund

publication date: Sep 23, 2016
FountainVest Partners, a China private equity investor, closed its third fund, FountainVest China Capital Partners Fund III, L.P., with $2.1 billion of committed capital. Healthcare and pharmaceuticals are an important sector for FountainVest. The firm said the fund was oversubscribed, with support from existing investors and new international global institutional investors. FountainVest seeks opportunities in which its expertise can help create additional value, with a focus on China's growing consumer economy. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital